Market Overview - The market experienced a volume contraction with the ChiNext index dropping nearly 2% by the end of the day. The synthetic biology concept stocks surged, with companies like Chuaning Biological, Jieya Co., and Meinong Biological hitting the daily limit. The shipping sector saw a rise and subsequent fall, with Ningbo Shipping, Ningbo Ocean, and Lianyungang achieving three consecutive limits. Consumer stocks in food, apparel, and beauty care were active, with Xiwang Food, Lafang Cosmetics, and Fengzhu Textile also hitting the daily limit. Conversely, the military industry faced adjustments, with Tianjian Technology nearing a limit down, and computing power concept stocks weakened, with Hongjing Technology dropping nearly 10%. Overall, over 3,800 stocks in the Shanghai and Shenzhen markets declined, with a total transaction volume of 1.19 trillion [1]. Hot Topics Health Products - Kolun Pharmaceutical's advertisement for ergothioneine capsules has sparked significant discussion, with Chairman Liu Gexin personally endorsing the product. Ergothioneine is a natural small molecule derived from histidine thiourea, found in microbial cells and plants. It cannot be synthesized by the human body and must be obtained through diet, with mushrooms being a key source. Sales of oral beauty products containing ergothioneine on a major e-commerce platform surged by 60 times year-on-year in the first half of 2024 [4][5]. Shipping - The shipping sector remained active, with Ningbo Ocean and Lianyungang achieving three consecutive limits. Following trade negotiations between China and the U.S., container shipping bookings from China to the U.S. surged nearly 300%, with the average booking volume for 20-foot standard containers skyrocketing to 21,530, up from 5,709 a week prior. Goldman Sachs anticipates a significant increase in Chinese exports over the next 90 days due to a tariff suspension [6][8]. Consumer Sector - The consumer sector was lively, with stocks like Marubi, Dengkang Dental, and Baiyang hitting the daily limit. The Tmall 618 promotion commenced, with the first hour's GMV for popular beauty products increasing over 10% year-on-year. Additionally, the price of tilapia has risen to 4.5 yuan per pound, with China being a major producer and exporter of tilapia, producing over 1.6 million tons annually, with about a quarter exported to the U.S. [9][10]. Stock Performance - Notable stocks in the health products sector include: - Jiaoda Aongli (600530.SS) with a price of 7.50, up 9.97%, and a market cap of 5.812 billion - Lafang Cosmetics with a price of 21.97, up 10.02%, and a market cap of 4.948 billion - Chuaning Biological with a price of 14.02, up 20.03%, and a market cap of 8.635 billion [5][10]. - In the shipping sector: - Ningbo Ocean (601022.SS) at 11.12, up 9.99%, with a market cap of 2.765 billion - Lianyungang (601008.SS) at 6.77, up 10.08%, with a market cap of 8.399 billion [7][10]. - In the consumer sector: - Zhejiang Yongqiang (002489.SZ) at 4.07, up 10.00%, with a market cap of 7.786 billion - Marubi (603983.SS) at 52.53, up 10.01%, with a market cap of 21.065 billion [10].

Group 1: International Market Development - The company has established a sales network in over 40 countries and regions, including Vietnam, Russia, Thailand, and Brazil, by the end of 2024 [3][10] - International market business revenue grew by over 25% year-on-year in 2024, with overseas business accounting for over 38% of total revenue [3][9] - The company aims to enhance its international market influence and position through increased investment and product launches along the "Belt and Road" initiative [3][9] Group 2: Competitive Advantages - The company has over 20 years of experience in international market development, establishing a unique brand image and a comprehensive sales network [4] - A high-quality, professional international team provides comprehensive services to overseas distributors and customers, enhancing brand value and differentiation [4] - The company actively participates in global exhibitions and forums to strengthen its brand presence in international markets [4] Group 3: Corn Protein Processing Project - The company is investing in a corn protein processing project with an annual capacity of 100,000 tons, addressing the domestic shortage of feed protein resources [5][6] - The project is expected to enhance the nutritional value and functionality of corn protein products, aligning with national industry policies [5][6] - Upon full completion, the project will provide a diverse product range, mitigating market volatility risks and expanding revenue growth opportunities [6][7] Group 4: Product Strategy and Market Focus - The company’s product strategy emphasizes "diversified nutrition" and focuses on pigs, ruminants, poultry, and aquaculture [12] - In 2024, the revenue breakdown for main products was 60.93% for functional feed additives, 19.97% for nutritional feed additives, and 12.84% for enzymatic protein feed materials, with growth rates of 6.77% and 9.81% respectively [11] - The company plans to enhance its product line and market presence through increased R&D investment and the introduction of high-value products [12]

Investment Rating - The report does not explicitly state an investment rating for the chemical industry, but it provides detailed insights into market performance and trends, indicating a cautious outlook for certain segments [2][11]. Core Insights - In April 2025, the basic chemical index decreased by 3.61%, ranking 20th among primary industries, with various sub-sectors experiencing different levels of performance [11][16]. - The apparent consumption of methanol in China has surpassed 100 million tons for the first time, indicating significant growth in demand [2]. - The report highlights a notable increase in the prices of key chemical products, particularly trichloroethylene, which rose by 16.28% due to supply constraints and strong demand in the refrigerant market [24][25]. Market Overview - Major indices in April 2025 showed declines: Shanghai Composite Index -1.70%, Shenzhen Component Index -5.75%, and ChiNext Index -7.40% [11]. - Among the basic chemical sub-sectors, the rubber and products segment saw a significant decline of 13.52%, while daily chemicals and inorganic salts experienced growth of 8.56% and 4.37%, respectively [16][20]. Product Price Movements - The top ten products with price increases included trichloroethylene (16.28%), ammonium sulfate (12.20%), and H acid (10.96%) [24][30]. - Conversely, the products with the largest price declines included TMA (-28.26%), bromine (-24.14%), and vitamin A (-18.07%) [30][32]. Company Performance - In April 2025, 221 basic chemical companies reported positive returns, while 319 companies experienced negative returns [20]. - The top-performing companies included United Chemical with a 159.09% increase and Hongbaoli with a 104.27% increase in stock price [21][22]. Industry Trends - The report notes that the chemical raw materials and products manufacturing industry achieved a total profit of 78.76 billion yuan in the first quarter, reflecting a slight decline of 0.4% year-on-year [34]. - Shandong province is focusing on enhancing its chemical industry advantages, with significant growth in the number of large-scale chemical enterprises and revenue generation [34].

Investment Rating - The report does not explicitly state an investment rating for the chemical industry Core Insights - In April 2025, the basic chemical index decreased by 3.61%, ranking 20th among primary industries, with 12 sub-industries showing growth and 20 experiencing declines [11][16][20] - The apparent consumption of methanol in China has surpassed 100 million tons for the first time [1] Market Overview - Major indices in April 2025 showed the following changes: Shanghai Composite Index -1.70%, Shenzhen Component Index -5.75%, ChiNext Index -7.40%, and North Securities 50 Index +4.72% [11] - The basic chemical sector's performance was mixed, with significant declines in rubber and related products, while daily chemical products and inorganic salts showed positive growth [16][20] Product Price Movements - The top ten products with price increases in April 2025 included Trichloroethylene (+16.28%), Ammonium Sulfate (+12.20%), and H Acid (+10.96%) [24][25] - Trichloroethylene prices rose significantly due to reduced production and strong demand in the refrigerant market [25][26] Sub-Industry Performance - Among the basic chemical sub-industries, the top five performers were daily chemicals (+8.56%), inorganic salts (+4.37%), and fluorochemicals (+3.46%), while polyurethane and tires saw the largest declines of -17.59% and -14.68%, respectively [16][19] - In April 2025, 221 companies in the basic chemical sector reported positive returns, while 319 reported negative returns [20] Company Performance - The top ten companies by monthly growth included United Chemical (+159.09%), Hongbaoli (+104.27%), and Zhongxin Fluorine Materials (+65.92%) [21][22] - Conversely, the bottom ten companies included Hunan YN (-22.18%), Dingjide (-22.54%), and Hengxing New Materials (-23.21%) [23][24] Industry News - In the first quarter of 2025, the chemical raw materials and products manufacturing industry achieved a total profit of 78.76 billion yuan, a slight decrease of 0.4% year-on-year [32] - Shandong province continues to enhance its chemical industry advantages, with 3,682 large-scale chemical enterprises and a revenue of 2.86 trillion yuan by the end of 2024 [32]

美农生物（301156）公告，股东李达计划自公告披露之日起15个交易日后的3个月内，以集中竞价和大 宗交易方式减持不超过422.35万股，占公司总股本的3%。截至公告日，李达持有公司3.64%股份。减持 原因为个人资金需求，减持价格将不低于公司发行价。 ...

中泰证券股份有限公司 | （四）保护公司利益不受侵害长效机制的建立和执行情况 | | | --- | --- | | 现场检查手段：查阅公司《公司章程》、《关联交易管理办法》、《对外担保管理制度》等相 | | | 关制度文件，查阅公司与关联交易相关的审议程序文件、信息披露文件，对相关人员进行访谈 等。 | | | 1.是否建立了防止控股股东、实际控制人及其关联人直接 | √ | | 或者间接占用上市公司资金或者其他资源的制度 | | | 2.控股股东、实际控制人及其关联人是否不存在直接或者 | √ | | 间接占用上市公司资金或者其他资源的情形 | | | 3.关联交易的审议程序是否合规且履行了相应的信息披露 | √ | | 义务 | | | 4.关联交易价格是否公允 | √ | | 5.是否不存在关联交易非关联化的情形 | √ | | 6.对外担保审议程序是否合规且履行了相应的信息披露义 √ 务 | | | 7.被担保方是否不存在财务状况恶化、到期不清偿被担保 √ | | | 债务等情形 | | | 8.被担保债务到期后如继续提供担保，是否重新履行了相 √ | | | 应的审批程序和披露义务 | | | （ ...

中泰证券股份有限公司 关于上海美农生物科技股份有限公司 2024 年度持续督导跟踪报告 | 保荐人名称：中泰证券股份有限公司 | 被保荐公司简称：美农生物 | | --- | --- | | 保荐代表人姓名：吴彦栋 | 联系电话：021-20235783 | | 保荐代表人姓名：嵇志瑶 | 联系电话：021-20235783 | 一、保荐工作概述 | 项目 | 工作内容 | | --- | --- | | 公司信息披露审阅情况 1. | | | （1）是否及时审阅公司信息披露文件 | 是 | | （2）未及时审阅公司信息披露文件的次数 | 0 次 | | 2. 督导公司建立健全并有效执行规章制度的情况 （1）是否督导公司建立健全规章制度（包括但不 | | | 限于防止关联方占用公司资源的制度、募集资金 | 是 | | 管理制度、内控制度、内部审计制度、关联交易 | | | 制度） | | | （2）公司是否有效执行相关规章制度 | 是 | | 3. 募集资金监督情况 | | | | 保荐机构每月查询公司募集资金专户资金使用 | | （1）查询公司募集资金专户次数 | 情况， 2024 年度共计查询 12 次 ...

Core Viewpoint - The company, Meino Biological, specializes in the research, production, and sales of feed additives and enzymatic protein feed materials, focusing on enhancing animal nutrition and health while improving feed efficiency and reducing costs [4][5][6]. Company Overview - Meino Biological is a high-tech enterprise engaged in the development, production, and sales of feed additives and enzymatic protein feed materials, with a product strategy of "divided by species and type, full-process nutrition" [4]. - The company's products are widely used in various animal husbandry sectors, including pigs, ruminants, poultry, and aquaculture, providing tailored solutions for different growth stages of animals [4]. Main Products and Applications - Functional feed additives include flavoring agents and acid regulators, aimed at improving feed quality and promoting animal growth [5]. - Nutritional feed additives consist of amino acids, vitamins, trace minerals, and enzyme preparations, with a competitive edge in controlled-release technology to enhance nutrient absorption [6]. - Enzymatic plant protein feed materials improve protein content and digestibility while reducing anti-nutritional factors, contributing to overall animal health and production performance [7]. Financial Data and Indicators - The company has undergone adjustments in accounting data, indicating a need for retrospective adjustments or restatements for previous years [8]. - The financial indicators for the recent three years are disclosed, with no significant discrepancies from previously reported quarterly or semi-annual reports [8]. Important Developments - In 2024, the company registered two invention patents and 16 utility model patents, enhancing its innovation capabilities [10]. - The establishment of wholly-owned subsidiaries in Shanghai and Le Ling, with registered capitals of 5 million and 100 million yuan respectively, indicates expansion efforts [10]. - The company participated in drafting several industry standards for feed additives, reflecting its commitment to industry leadership and quality standards [10].

关于组织架构调整的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有 虚假记载、误导性陈述或重大遗漏。 上海美农生物科技股份有限公司（以下简称"公司"）于 2025 年 4 月 24 日 召开的第五届董事会第十一次会议，审议通过了《关于公司组织架构调整的议案》。 为进一步完善公司治理结构，整合资源配置，提升公司整体运营效率与管理 水平，根据有关法律法规、规范性文件及《公司章程》的有关规定，结合公司战 略发展规划及实际经营发展情况，对现有组织架构进行了调整： 证券代码：301156 证券简称：美农生物 公告编号：2025-032 上海美农生物科技股份有限公司 （1）根据《关于新<公司法>配套制度规则实施相关过渡期安排》等相关规 定，并结合公司实际情况，优化公司治理结构； 董事会 2025 年 4 月 26 日 （2）新增全资子公司上海优立恩动物营养科技有限公司（简称"优立恩"）， 拓展公司进出口业务； （3）新增全资子公司美农生物科技（乐陵）有限公司（简称"乐陵美农"）， 实施公司年产 10 万吨的玉米蛋白精加工项目； （4）将市场部合并到国内营销中心，整合提升国内营销工作协同力。 本次组织架 ...

证券代码：301156 证券简称：美农生物 公告编号：2025-034 上海美农生物科技股份有限公司 关于举行 2024 年度网上业绩说明会的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有 虚假记载、误导性陈述或重大遗漏。 欢迎广大投资者积极参与本次网上说明会。 （问题征集专题页面二维码） 特此公告。 上海美农生物科技股份有限公司 董事会 2025 年 4 月 26 日 上海美农生物科技股份有限公司（以下简称"公司"）定于 2025 年 5 月 19 日（星期一）15:00 至 17:00 在全景网举办 2024 年度业绩说明会，本次年度业 绩说明会将采用网络远程的方式举行，投资者可登录全景网"投资者关系互动平 台"（https://ir.p5w.net）参与本次年度业绩说明会。 出席本次说明会的人员有：公司董事长兼总经理洪伟先生，财务总监周茜女 士，董事会秘书张维娓女士，独立董事向川先生，保荐代表吴彦栋先生。 为充分尊重投资者、提升交流的针对性，现就公司 2024 年度业绩说明会提 前向投资者公开征集问题，广泛听取投资者的意见和建议。投资者可于 2025 年 5 月 19 日 15:0 ...